PMC Inpatients Jan-June 2011
Antimicrobial Agent Abbreviations
Amp- Ampicilin, Amox/Clav- Amoxicillin/Clavulanate, Amp/Sulb-Ampicillin/Sulbactam, Amik- Amikacin, Aztre-Aztreonam, Cefaz- Cefazolin, Ceftaz-Ceftazidime, Cefep-Cefepime, Chloro-Chloramphenicol, Clinda-Clindamycin, Eryth-Erythromycin, Gent-Gentamicin, Imip-Imipenem, Levo-Levofloxacin,Linz-Linezolid, Mero-Meropenem, Nitro-Nitrofurantoin, Norflox- Norfloxacin, Naf-Nafcillin, Pen-Penicillin, Pip/Tazo-Pipercillin/Tazobactam, Quin-Dalf-Quinupristin-Dalfopristin, Tetra-Tetracycline, Tmp/Sxt- Trimethoprim/Sulfamethoxazole, Tobra-Tobramycin, Vanco-Vancomycin
PMC Inpatients, Jan-June 2011, Blood Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Amp/Sulb	Cefaz	Clinda	Eryth	Gent(Strep)	Naf	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	95	2	53	53	53	42	98	52	98	60	97	100	100	100
Staphylococcus epi	33	0	33	33	46	36	82	33	nt	27	91	100	100	100
Enterococcus sp	31	52	nt	R**	R**	nt	84hl (60hl)	nt	R**	23	13	100	nt	61
** intrinsic resistance		*hl- high level gentamicin, 500 ug/ml, high level streptomycin, 2000 ug/ml, in parenthesis
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Pip (Pip/Tazo)	Tmp/Sxt	Mero
E. coli	25	48	80	61	88	96	84	88	100	60	48(100)	60	100
PMC Inpatients, Jan-June, 2011 Non-Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Clinda	Ery	Gent	Naf	Tmp/Sxt	Levo	Tetra	Linz	Nitro	Quin-Dalf	Vanco
S. aureus	323	1	50	57	32	98	50	95	55	92	100	99	100	100
Staphylococcus epidermidis	11	0	46	36	36	46	46	nt	55	100	100	100	100	100
Enterococcus sp	85	74	R**	nt	nt	nt	nt	R**	51	20	100	nt	nt	73
** intrinsic resistance
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefep	Gent	Tobra	Amik	Levo	Mero	Pip (Pip/Tazo)	Tmp/Sxt
E. cloacae	15	R**	R**	R**	73	93	100	100	100	100	100	67(73)	93
E. coli	52	31	69	48	90	92	81	77	100	37	100	37(91)	56
K. pneumoniae	28	R**	50	24	46	61	50	54	79	54	68	0(43)	46
M. morganii	10	0	0	0	90	100	100	100	100	80	100	80(100)	80
P. mirabilis	15	87	87	75	100	93	93	87	100	73	100	87(100)	80
P. aeruginosa	64	R**	R**	R**	78	86	61	83	95	60	69	77	R**
S. marcescens	10	R**	R**	R**	100	100	100	100	100	100	100	90(90)	100
** intrinsic resistance
PMC Inpatients, Jan-June 2011, Urinary Isolates
					Percent Susceptible
Organism	No	Amp or Pen	Cefaz	Ery	Clinda	Gent	Naf	Nitro	Tmp/Sxt	Levo	Tetra	Linz	Quin-Dalf	Vanco
S. aureus	22	0	64	55	64	95	64	100	91	50	96	100	100	100
Staphylococcus, coag neg	51	0	47	47	65	75	47	100	nt	82	82	100	100	100
Enterococcus sp	141	72	R**	nt	nt	nt	nt	71	R**	check	25	100	nt	72
** intrinsic resistance
					Percent Susceptible
Organism	No.	Amp	Amp/Sulb or Amox/Clav	Cefaz	Ceftaz	Cefp	Gent	Tobra	Amik	Levo	Norflox	Nitro	Pip (Pip/Tazo)	Tmp/Sxt	Tetra	Mero
E. coli	189	46	78	81	94	94	89	92	100	59	59	95	48(100)	71	74	100
K. pneumoniae	45	R**	80	67	67	76	78	71	87	78	69	36	0(83)	64	80	87
P. mirabilis	25	88	92	84	100	100	88	92	100	52	64	0	88(100)	80	0	nt
P. aeruginosa	22	R**	R**	R**	100	100	82	100	100	68	nt	nt	95	nt	nt	100
** intrinsic resistance